In this review, we consider issues relating to the pharmacological treatment of young
children with attention deficit hyperactivity disorder (ADHD). ADHD in preschool-age …

Approximately one-half of children medicated for attention-deficit hyperactivity disorder
(ADHD) will continue to experience sufficient impairment during adolescence to warrant the …

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder
with a childhood onset of symptoms and impairment. Although it is most frequently identified …

The central role of medication in the treatment of attention-deficit hyperactivity disorder
(ADHD) in children and adolescents is the focus of controversy once more. Questions about …

The prevalence, impairment, and poor outcome associated with% ADHD% in childhood
provide a clarion call for the application of effective treatment strategies to youngsters with …

Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed
behavioral disorders among children in the United States, affecting approximately 3%-5% of …

Pharmacologic intervention for attention-deficit hyperactivity disorder (ADHD) in preschool
children is a controversial issue. Non-pharmacologic interventions (psychosocial and …

Attention deficit hyperactivity disorder (ADHD) is common in children, adolescents, and
adults, with extensive research establishing it as a valid neurobiological disorder. Without …

Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in
children and adolescents. ADHD affects multiple aspects of an individual's life and …

Attention deficit hyperactivity disorder (ADHD) is a neurobehavioral developmental disorder
found in 3% to 8% of children and adolescents. An important part of ADHD management is …